Libbs Ventures

Funding rounds backed by Libbs Ventures.

Export CSV
Funding disclosed in full
$77M
Median round
$77M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Crossbow Therapeutics

Develops a novel class of potent and precise antibody therapies to treat a broad range of cancers

$77MSeries BBiotechUnited States
13 participantsArkin Bio CapitalBlood Cancer United's Therapy Acceleration ProgramBVF PartnersEli Lilly and CompanyHamilton Square PartnersLibbs VenturesLifeLink VenturesMirae Asset Venture InvestmentMPM BioImpactPfizer VenturesPolaris PartnersSixty Degree CapitalTaiho Ventures